Optiver Holding’s KalVista Pharmaceuticals KALV Stock Holding History

Optiver Holding’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,591	Closed	-$92.4K	–	2940
2026 Q1	$92.4K	Buy	4,591 +4,442	+2,981%	+$71.6K	﹤0.01%	898
2025 Q4	$2.41K	Sell	149 -61	-29%	-$808	﹤0.01%	1911
2025 Q3	$2.56K	Buy	+210	New	+$2.9K	﹤0.01%	2275

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Optiver Holding's KALV Position: Q2 2026 in Review

Optiver Holding sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 4,591 shares — an estimated $92.4K sold.

Optiver Holding first reported a position in KALV in Q3 2025 and held it in 3 quarters. The position peaked at $92.4K in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

Optiver Holding reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Optiver Holding sold 4,591 KalVista Pharmaceuticals shares in Q2 2026, an estimated $92.4K.
Optiver Holding first reported a position in KalVista Pharmaceuticals in Q3 2025 and held it in 3 quarters.
Optiver Holding's KalVista Pharmaceuticals position peaked at $92.4K in Q1 2026.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.